Clinical Trials
15
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (15 trials with phase data)โข Click on a phase to view related trials
Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine
- Conditions
- Vaccine ReactionVaccination; InfectionInfluenza, HumanInfluenza Viral InfectionsInfluenza
- First Posted Date
- 2023-05-22
- Last Posted Date
- 2023-05-22
- Target Recruit Count
- 450
- Registration Number
- NCT05869201
- Locations
- ๐ท๐บ
Federally Funded Healthcare Institution Primary Healthcare Unit No. 163,of Federal Medical and Biologic Agency (FFHI PHU No. 163, FMBA of Russia), Kol'tsovo, Novosibirsk Region, Russian Federation
๐ท๐บBessalar Clinic. Clinical Trial Center Limited Liability Company (Bessalar Clinic. Clinical Trial Center LLC), Moscow, Russian Federation
๐ท๐บFederation (FSBEI of Higher Education "E. A. Wagner PSMU" of the of the Ministry of Health of the Russian Federation), Perm, Russian Federation
Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children
- Conditions
- InfluenzaVaccine ReactionInfluenza, HumanInfluenza Viral Infections
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-08-30
- Target Recruit Count
- 948
- Registration Number
- NCT05739474
- Locations
- ๐ท๐บ
State Autonomous Health Care Institution of the Sverdlovsk Region "Children's City Clinical Hospital No. 11", Ekaterinburg, Russian Federation
๐ท๐บState Autonomous Health Care Institution "Engels City Clinical Hospital No1", Engel's, Russian Federation
๐ท๐บLlc "Olla-Med", Moscow, Russian Federation
Immunogenicity, Efficacy and Safety Trial of the Convacell Vaccine in Healthy Volunteers Aged 18 Years and Older
- Conditions
- COVID-19Coronavirus InfectionsCOVID-19 Respiratory InfectionRespiratory Tract Infections
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2023-08-30
- Target Recruit Count
- 16304
- Registration Number
- NCT05726084
- Locations
- ๐ท๐บ
Limited Liability Company "OLLA-MED", Moscow, Russian Federation
๐ท๐บState budgetary health care institution of the city of Moscow "City Clinical Hospital No. 24 of the Department of Health of the City of Moscow", Moscow, Russian Federation
๐ท๐บLimited Liability Company "Scientific Research Center Eco-Safety", Saint Petersburg, Russian Federation
Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old
- Conditions
- VaccinesInfluenza, HumanVaccination; Infection
- First Posted Date
- 2022-07-22
- Last Posted Date
- 2022-07-22
- Target Recruit Count
- 1066
- Registration Number
- NCT05470582
- Locations
- ๐ท๐บ
LLC "Energiya zdorov'ya", Saint Petersburg, Russian Federation
๐ท๐บSt. Petersburg State Budgetary Institution of Health Care "Children's City Polyclinic No. 45" of the Nevsky District, Saint Petersburg, Russian Federation
Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women
- Conditions
- Influenza, HumanVaccinesVaccination; Infection
- First Posted Date
- 2022-07-14
- Last Posted Date
- 2022-07-14
- Target Recruit Count
- 207
- Registration Number
- NCT05457894
- Locations
- ๐ท๐บ
Federal State Budgetary Educational Institution of Higher Education "Altai State Medical University" of the Ministry of Health of the Russian Federation, Barnaul, Altai Territory, Russian Federation
๐ท๐บFederal State Budgetary Institution "Siberian Federal Scientific and Clinical Center of Federal Medical and Biologic Agency", Seversk, Tomsk Region, Russian Federation
๐ท๐บMunicipal Budgetary Institution "Central City Hospital No.7", Ekaterinburg, Russian Federation
- Prev
- 1
- 2
- 3
- Next